Predicted Trait | |
Reported Trait | ER-negative breast cancer |
Mapped Trait(s) | estrogen-receptor negative breast cancer (EFO_1000650) |
Score Construction | |
PGS Name | PRS3820_ERneg |
Development Method | |
Name | LASSO penalized regression |
Parameters | p < 0.001 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 3,820 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000002 |
Citation (link to publication) | Mavaddat N et al. Am J Hum Genet (2018) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
— | [ ,
0.0 % Male samples |
European | 68 cohorts
|
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [ ,
0.0 % Male samples |
European | 25 cohorts
|
ER-negative breast cancer cases | — | — | — | Validation Cohort |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000010 | PSS000006| European Ancestry| 11,428 individuals |
PGP000002 | Mavaddat N et al. Am J Hum Genet (2018) |
Reported Trait: ER-negative breast cancer | OR: 1.44 [1.36, 1.53] | AUROC: 0.6 | — | study, genetic PCs 1-15 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000006 | ER-negative breast cancer cases | — | [ ,
0.0 % Male samples |
— | European | — | 10 cohorts
|
Prospective Test Set |